Document is current
Any future updates will be listed below
-
Authors
Muhammad Ali, Peshawa J. https://orcid.org/0000-0002-0471-5172
Vincent, Navin https://orcid.org/0000-0003-2894-6319
Abdulla, Saman S.
Mohammed Fadhl, Han N.
Blilie, Anders
Szolnoky, Kelvin
Mielcarz, Julia Anna
Ji, Xiaoyi
Mulliqi, Nita
Al-Talabani, Abdulbasit K.
Kartasalo, Kimmo https://orcid.org/0000-0002-9470-4783
-
Funding
Funding for this research was provided by:
Knut och Alice Wallenbergs Stiftelse (KAW 2024.0159)
Instrumentariumin Tiedesäätiö (Instrumentariumin Tiedesäätiö)
Karolinska Institutet (Karolinska Institutet)
Cancerfonden (25 4893 Pj)
- License Information
-
More Information
Article History
Received: 15 May 2026
Revised: 18 September 2026
Accepted: 3 October 2026
First Online: 10 October 2026
Declarations
Compliance with ethical standards: The patient sample collection was approved by the Ethical Committee of PAR Hospital in Kurdistan, Iraq (permit 1002/07072024). Digital scanning and processing of the samples at Karolinska Institutet was approved by the Swedish Ethical Review Authority (permit 2019–05220). The samples were de-identified before shipping to Karolinska Institutet. Informed consent was waived by the ethical review board due to the use of de-identified prostate specimens in a retrospective setting. This study complies with the Helsinki Declaration.
Conflict of interests: N.M. and K.K. are shareholders of Clinsight AB. Other authors declare no competing interests.
